The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALIBABA GROUP HLDG LTD SPONSORED ADS 01609W102 BBG006G2JVQ7 604,404 6,968 SH   SOLE N/A 6,968 0 0
ALIBABA GROUP HLDG LTD SPONSORED ADS 01609W102   18,832,000 220,000 SH Call SOLE N/A 220,000 0 0
ALPHABET INC CAP STK CL A 02079K305   1,962,900 15,000 SH Call SOLE N/A 15,000 0 0
YS BIOPHARMA CO LTD *W EXP 03/15/202 G9845F117 BBG01FY54DL0 19,250 550,000 SH   SOLE N/A 550,000 0 0